Company / Free Cash Flow
Organogenesis Holdings Inc. Free Cash Flow History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$6.6M
FY2025
5-year range
-$39.5M / $30.8M
FY2021-FY2025
Trend
+172.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has fluctuated over the past 8 years, ranging from -$62M in FY2020 to $31M in FY2023.
Based on SEC 10-K filings.
$7M in FY2025.
Declined from $31M to $7M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow increased 172.5% year-over-year.
- Peak free cash flow was recorded in FY2023.
- Lowest free cash flow in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.6M | +172.5% |
| FY2024 | -$9.0M | -129.4% |
| FY2023 | $30.8M | +351.9% |
| FY2022 | -$12.2M | +69.1% |
| FY2021 | -$39.5M | +36.8% |
| FY2020 | -$62.5M | -955.8% |
| FY2019 | -$5.9M | +5.0% |
| FY2018 | -$6.2M | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026